Skip to main content
SpringerLink
Log in

Das Mikrobiom beim benignen Prostatasyndrom

The microbiome in benign prostatic hyperplasia

  • Leitthema
  • Published:
Der Urologe Aims and scope Submit manuscript

Zusammenfassung

Aufgrund der Entwicklung neuer Hochdurchsatzsequenzierungstechniken wurde der Grundstein zur Erforschung des Mikrobioms gelegt, wodurch neue Perspektiven auf eine bisher nicht vorstellbare Komplexität und Diversität einer Vielzahl von Ökosystemen des menschlichen Körpers eröffnet wurden. Eine der Haupterkenntnisse war, dass das seit Jahrzehnten bestehende Dogma eines sterilen Harntraktes nicht mehr haltbar ist. Wie für alle Nischen des menschlichen Körpers ist auch hier ein ausgeglichenes Mikrobiom wichtiger Bestandteil für die physiologische Funktionsweise des Harntraktes und somit Voraussetzung für die Gesundheit. Die Dysbalance des Mikrobioms wird mittlerweile als wichtiger Einflussfaktor für die Entstehung von Krankheiten angesehen. In der Urologie konnten bisher wichtige Erkenntnisse gewonnen werden sowohl zu benignen Erkrankungen wie der interstitiellen Zystitis, der Dranginkontinenz und der chronischen Prostatitis/chronischem Beckenschmerzsyndrom als auch zur Beteiligung an malignen Erkrankungen wie dem Prostatakarzinom. Auch Beschwerdekomplexe wie das benigne Prostatasyndrom sind mittlerweile in den Vordergrund der Forschungsbestrebungen gerückt und das Mikrobiom des Harntraktes scheint eine bisher ungeahnte Rolle für die Pathogenese und Progression dieser Volkskrankheit zu spielen.

Abstract

The advent of new high throughput sequencing technologies has paved the way for microbiome research, opening up entirely new perspectives on the complex and diverse ecosystems of the human body. One of the main findings was that it became clear that in contrast to the widely held dogma the urinary tract is not a sterile environment. As for all niches of the human body, a well-balanced microbiome is an essential part for the physiological functioning of the urinary tract and therefore it must be considered a prerequisite for health. The dysbalance of the microbiome is now seen as having a considerable impact on the pathogenesis of a plethora of diseases. Its role in benign disorders, such as interstitial cystitis, urinary urge incontinence and chronic prostatitis/chronic pelvic pain syndrome as well as participation in malignant conditions, such as prostate cancer has recently been revealed. The contribution of the urinary microbiome to the pathogenesis and progression of lower urinary tract symptoms due to benign prostatic obstruction are currently under investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Human Microbiome Project C (2012) Structure, function and diversity of the healthy human microbiome. Nature 486(7402):207–214

    Article  Google Scholar 

  2. Human Microbiome Project C (2012) A framework for human microbiome research. Nature 486(7402):215–221

    Article  Google Scholar 

  3. Darbro BW, Petroelje BK, Doern GV (2009) Lactobacillus delbrueckii as the cause of urinary tract infection. J Clin Microbiol 47(1):275–277

    Article  Google Scholar 

  4. Maskell R, Pead L, Sanderson RA (1983) Fastidious bacteria and the urethral syndrome: a 2-year clinical and bacteriological study of 51 women. Lancet 2(8362):1277–1280

    Article  CAS  Google Scholar 

  5. Siddiqui H, Lagesen K, Nederbragt AJ, Jeansson SL, Jakobsen KS (2012) Alterations of microbiota in urine from women with interstitial cystitis. BMC Microbiol 12:205

    Article  Google Scholar 

  6. Abernethy MG, Rosenfeld A, White JR, Mueller MG, Lewicky-Gaupp C, Kenton K (2017) Urinary microbiome and cytokine levels in women with interstitial cystitis. Obstet Gynecol 129(3):500–506

    Article  CAS  Google Scholar 

  7. Sidaway P (2017) Pain: changes in urinary microbiota correlate with IC/BPS. Nat Rev Urol 14(5):260

    Article  Google Scholar 

  8. Yildirim S, Shoskes D, Kulkarni S, Laguna P (2020) Urinary microbiome in uncomplicated and interstitial cystitis: is there any similarity? World J Urol. https://doi.org/10.1007/s00345-020-03099-x

    Article  PubMed  Google Scholar 

  9. Karstens L, Asquith M, Davin S, Stauffer P, Fair D, Gregory WT et al (2016) Does the urinary microbiome play a role in urgency urinary incontinence and its severity? Front Cell Infect Microbiol 6:78

    Article  Google Scholar 

  10. Pearce MM, Hilt EE, Rosenfeld AB, Zilliox MJ, Thomas-White K, Fok C et al (2014) The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio 5(4):e01283–14

    Article  Google Scholar 

  11. Thomas-White KJ, Hilt EE, Fok C, Pearce MM, Mueller ER, Kliethermes S et al (2016) Incontinence medication response relates to the female urinary microbiota. Int Urogynecol J 27(5):723–733

    Article  Google Scholar 

  12. Nickel JC, Stephens A, Landis JR, Chen J, Mullins C, van Bokhoven A et al (2015) Search for microorganisms in men with urologic chronic pelvic pain syndrome: a culture-independent analysis in the MAPP research network. J Urol 194(1):127–135

    Article  Google Scholar 

  13. Shoskes DA, Altemus J, Polackwich AS, Tucky B, Wang H, Eng C (2016) The urinary microbiome differs significantly between patients with chronic prostatitis/chronic pelvic pain syndrome and controls as well as between patients with different clinical phenotypes. Urology 92:26–32

    Article  Google Scholar 

  14. Ficarra V, Rossanese M, Zazzara M, Giannarini G, Abbinante M, Bartoletti R et al (2014) The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy. Curr Urol Rep 15(12):463

    Article  Google Scholar 

  15. Gandaglia G, Zaffuto E, Fossati N, Cucchiara V, Mirone V, Montorsi F et al (2017) The role of prostatic inflammation in the development and progression of benign and malignant diseases. Curr Opin Urol 27(2):99–106

    Article  Google Scholar 

  16. Shrestha E, White JR, Yu SH, Kulac I, Ertunc O, De Marzo AM et al (2018) Profiling the urinary microbiome in men with positive versus negative biopsies for prostate cancer. J Urol 199(1):161–171

    Article  Google Scholar 

  17. Yu H, Meng H, Zhou F, Ni X, Shen S, Das UN (2015) Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia. Arch Med Sci 11(2):385–394

    Article  Google Scholar 

  18. Bosch JL, Bangma CH, Groeneveld FP, Bohnen AM (2008) The long-term relationship between a real change in prostate volume and a significant change in lower urinary tract symptom severity in population-based men: the Krimpen study. Eur Urol 53(4):819–825 (discussion 25–7)

    Article  Google Scholar 

  19. Parsons JK, Wilt TJ, Wang PY, Barrett-Connor E, Bauer DC, Marshall LM et al (2010) Progression of lower urinary tract symptoms in older men: a community based study. J Urol 183(5):1915–1920

    Article  Google Scholar 

  20. Roehrborn CG (2008) BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE. BJU Int 101(Suppl 3):17–21

    Article  Google Scholar 

  21. Lewis DA, Brown R, Williams J, White P, Jacobson SK, Marchesi JR et al (2013) The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults. Front Cell Infect Microbiol 3:41

    Article  Google Scholar 

  22. Bajic P, Van Kuiken ME, Burge BK, Kirshenbaum EJ, Joyce CJ, Wolfe AJ et al (2020) Male bladder microbiome relates to lower urinary tract symptoms. Eur Urol Focus 6(2):376–382

    Article  Google Scholar 

  23. Wolfe AJ, Toh E, Shibata N, Rong R, Kenton K, Fitzgerald M et al (2012) Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol 50(4):1376–1383

    Article  Google Scholar 

  24. Holland B, Karr M, Delfino K, Dynda D, El-Zawahry A, Braundmeier-Fleming A et al (2020) The effect of the urinary and faecal microbiota on lower urinary tract symptoms measured by the International Prostate Symptom Score: analysis utilising next-generation sequencing. BJU Int 125(6):905–910

    CAS  PubMed  Google Scholar 

  25. Aragon IM, Herrera-Imbroda B, Queipo-Ortuno MI, Castillo E, Del Moral JS, Gomez-Millan J et al (2018) The urinary tract microbiome in health and disease. Eur Urol Focus 4(1):128–138

    Article  Google Scholar 

  26. Magistro G, Stief CG (2019) The urinary tract microbiome: the answer to all our open questions? Eur Urol Focus 5(1):36–38

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Urologische Klinik und Poliklinik, Klinikum der Universität München, Ludwig-Maximilians-Universität, Marchioninistraße 15, 81377, München, Deutschland

    G. Magistro & C. G. Stief

  2. Klinik für Urologie und Kinderurologie, Universitätsklinikum des Saarlandes, Homburg/Saar, Deutschland

    C. Füllhase

  3. Klinik für Urologie, Andrologie und Kinderurologie, Klinikum Weiden/Kliniken Nordoberpfalz AG, Söllnerstr. 16, 92637, Weiden, Deutschland

    T. Bschleipfer

Authors
  1. G. Magistro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Füllhase
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. G. Stief
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Bschleipfer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Magistro.

Ethics declarations

Interessenkonflikt

G. Magistro, C. Füllhase, C.G. Stief und T. Bschleipfer geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Magistro, G., Füllhase, C., Stief, C.G. et al. Das Mikrobiom beim benignen Prostatasyndrom. Urologe 59, 1204–1207 (2020). https://doi.org/10.1007/s00120-020-01318-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-020-01318-2

Schlüsselwörter

Keywords

Search

Navigation